These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9398931)

  • 1. Managing disability benefits as part of treatment for persons with severe mental illness and comorbid drug/alcohol disorders. A comparative study of payee and non-payee participants.
    Ries RK; Comtois KA
    Am J Addict; 1997; 6(4):330-8. PubMed ID: 9398931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Representative payee practices of community mental health centers in Washington State.
    Ries RK; Dyck DG
    Psychiatr Serv; 1997 Jun; 48(6):811-4. PubMed ID: 9175191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance use and assignment of representative payees.
    Rosen MI; Rosenheck R
    Psychiatr Serv; 1999 Jan; 50(1):95-8. PubMed ID: 9890587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of representative payees on substance use by homeless persons with serious mental illness.
    Rosenheck R; Lam J; Randolph F
    Psychiatr Serv; 1997 Jun; 48(6):800-6. PubMed ID: 9175189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does assigning a representative payee reduce substance abuse?
    Rosen MI; McMahon TJ; Rosenheck R
    Drug Alcohol Depend; 2007 Jan; 86(2-3):115-22. PubMed ID: 16839710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment.
    Jerrell JM; Ridgely MS
    Psychiatr Serv; 1995 Mar; 46(3):233-8. PubMed ID: 7796208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe mental illness and substance use disorders among former Supplemental Security Income beneficiaries for drug addiction and alcoholism.
    Swartz JA; Lurigio AJ; Goldstein P
    Arch Gen Psychiatry; 2000 Jul; 57(7):701-7. PubMed ID: 10891041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term course of substance use disorders among patients with severe mental illness.
    Bartels SJ; Drake RE; Wallach MA
    Psychiatr Serv; 1995 Mar; 46(3):248-51. PubMed ID: 7796211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent validity of clinicians' ratings of substance abuse among psychiatric outpatients.
    Carey KB; Cocco KM; Simons JS
    Psychiatr Serv; 1996 Aug; 47(8):842-7. PubMed ID: 8837156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting compliance of dual diagnosis inpatients with aftercare treatment.
    Wolpe PR; Gorton G; Serota R; Sanford B
    Hosp Community Psychiatry; 1993 Jan; 44(1):45-9. PubMed ID: 8382186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief integrated outpatient dual-diagnosis treatment reduces psychiatric hospitalizations.
    Granholm E; Anthenelli R; Monteiro R; Sevcik J; Stoler M
    Am J Addict; 2003; 12(4):306-13. PubMed ID: 14504023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of alcohol and other drug disorders in the seriously mentally ill.
    Barry KL; Fleming MF; Greenley J; Widlak P; Kropp S; McKee D
    Schizophr Bull; 1995; 21(2):313-21. PubMed ID: 7631177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial Capability: Clinicians' Assessment of Beneficiaries With Dual Diagnoses.
    Thornhill Iv TA; Black AC; Rosen MI
    J Dual Diagn; 2018; 14(2):130-136. PubMed ID: 29505348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An agency-based representative payee program and improved community tenure of persons with mental illness.
    Luchins DJ; Hanrahan P; Conrad KJ; Savage C; Matters MD; Shinderman M
    Psychiatr Serv; 1998 Sep; 49(9):1218-22. PubMed ID: 9735966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of case manager ratings and weekly urine toxicology tests among outpatients with dual diagnoses.
    Ries RK; Dyck DG; Short R; Srebnik D; Snowden M; Comtois KA
    Psychiatr Serv; 2002 Jun; 53(6):764-6. PubMed ID: 12045318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of managing disability benefits among patients with substance dependence and severe mental illness.
    Ries RK; Dyck DG; Short R; Srebnik D; Fisher A; Comtois KA
    Psychiatr Serv; 2004 Apr; 55(4):445-7. PubMed ID: 15067161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of retroactive disability payments on recipients' compliance with substance abuse treatment.
    Satel S; Reuter P; Hartley D; Rosenheck R; Mintz J
    Psychiatr Serv; 1997 Jun; 48(6):796-9. PubMed ID: 9175188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of public support payments to substance abuse among homeless veterans with mental illness.
    Frisman LK; Rosenheck R
    Psychiatr Serv; 1997 Jun; 48(6):792-5. PubMed ID: 9175187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 'check effect' reconsidered.
    Rosen MI
    Addiction; 2011 Jun; 106(6):1071-7. PubMed ID: 21338431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.